Skip to content

Drug interactions

Pacritinib + Temsirolimus

Severity: Moderate

Pacritinib and Temsirolimus: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pacritinib inhibits P-glycoprotein and could increase temsirolimus exposure. This may increase mTOR inhibitor adverse effects such as mucositis, cytopenias and infection.

What this interaction means in plain words

Pacritinib and Temsirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Pacritinib belongs to Oncology; Temsirolimus belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of P-gp efflux, reducing temsirolimus elimination.

What to do

Monitor for temsirolimus toxicity and blood counts; consider a temsirolimus dose reduction if adverse effects emerge.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pacritinib and Temsirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Pacritinib with Temsirolimus?

MediHelp rates the interaction as moderate. Pacritinib and Temsirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pacritinib inhibits P-glycoprotein and could increase temsirolimus exposure. This may increase mTOR inhibitor adverse effects such as mucositis, cytopenias and infection.

How serious is the interaction between Pacritinib and Temsirolimus?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for temsirolimus toxicity and blood counts; consider a temsirolimus dose reduction if adverse effects emerge.

What other medicines interact with Temsirolimus?

MediHelp also lists interactions of Temsirolimus with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine live. The full list is on the Temsirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in